Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-06

Clinical Trial Update: Evaluation of Liposomal Bupivacaine Compared to Usual Care and Its Effects on Pain for Cardiac Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating liposomal bupivacaine versus usual care for postoperative pain after cardiac surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Florida Heart and Lung Institute | Conditions: Cardiothoracic Surgery | Phase 4 | Status: UNKNOWN